Get Interstitial Lung Disease Treatment Online

Interstitial lung disease is an umbrella term for a large group of disorders that cause progressive inflammation and scarring of the interstitium, the tissue and space surrounding the lung's air sacs. This scarring can stiffen the lungs and make breathing increasingly difficult over time.

The most common symptoms are a persistent dry cough and progressive shortness of breath, especially with physical activity. Some patients also experience fatigue, unintentional weight loss, and in advanced cases, low blood oxygen levels.

ILD can result from many causes including autoimmune diseases such as rheumatoid arthritis and scleroderma, long-term exposure to hazardous substances like asbestos or silica, certain medications, and infections. In many cases, no identifiable cause is found, and the condition is called idiopathic.

Diagnosis typically involves a high-resolution CT scan of the chest, pulmonary function tests to measure lung capacity and airflow, blood tests to check for autoimmune markers, and sometimes a bronchoscopy or surgical lung biopsy. A specialist in pulmonology usually leads the diagnostic workup.

There is currently no cure for most forms of ILD, but treatment can slow progression, relieve symptoms, and improve quality of life. Options include corticosteroids, immunosuppressants, antifibrotic medications, pulmonary rehabilitation, supplemental oxygen, and in select cases, lung transplantation.

Pulmonary fibrosis is one specific type of ILD characterized by lung scarring. Idiopathic pulmonary fibrosis (IPF) is the most well-known form. All pulmonary fibrosis is a type of ILD, but not all ILD results in pulmonary fibrosis. There are many ILD subtypes with different underlying causes and treatments.

Doctronic uses an AI-guided evaluation to gather detailed information about your symptoms, medical history, and current medications. A licensed physician then reviews your case, discusses management options, and can support your ongoing care or coordinate with your existing pulmonology team.

Yes. Doctronic's evaluations are conducted and reviewed by licensed physicians. The platform is HIPAA-compliant and designed with patient safety as the top priority. All care decisions are made by qualified medical professionals, not by the AI alone.